Abstract:Neurodegenerative diseases are characterized by chronic progressive degeneration of the structure and function of the nervous system, which brings an enormous burden on patients, their families, and society. It is difficult to make early diagnosis, resulting from the insidious onset and progressive development of neurodegenerative diseases. The drugs on the market cannot cross the blood–brain barrier (BBB) effectively, which leads to unfavorable prognosis and less effective treatments. Therefore, there is an urgent demand to develop a novel detection method and therapeutic strategies. Recently, nanomedicine has aroused considerable attention for diagnosis and therapy of central nervous system (CNS) diseases. Nanoparticles integrate targeting, imaging, and therapy in one system and facilitate the entry of drug molecules across the blood–brain barrier, offering new hope to patients. In this review, we summarize the application of iron oxide nanoparticles (IONPs) in the diagnosis and treatment of neurodegenerative disease, including Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS). We focus on IONPs as magnetic resonance imaging (MRI) contrast agents (CAs) and drug carriers in AD. What most neurodegenerative diseases have in common is that hall marker lesions are represented by protein aggregates (<a href="#B58">Soto and Pritzkow, 2018</a>). These diseases are of unknown etiology and unfavorable prognosis, and the treatments toward them are less effective (<a href="#B58">Soto and Pritzkow, 2018</a>). Such diseases usually develop in aged people, and early clinical manifestations are atypical, resulting in difficulty in early diagnosis. Recently, nanomedicine has aroused considerable attention for therapy and diagnosis of CNS diseases because it integrates targeting, imaging, and therapy in one system (<a href="#B30">Gupta et al., 2019</a>). In this review article, we first introduce the neurodegenerative diseases and commonly used MRI CAs. Then we review the application of IONPs in the diagnosis and treatment of neurodegenerative diseases with the purpose of assisting early theranostics (therapy and diagnosis).

Progress of advanced nanomaterials in diagnosis of neurodegenerative diseases

Application of Nanomaterials in Neurodegenerative Diseases

Application of nanotechnology for diagnosis of Alzheimer's disease

Emerging two-dimensional materials-based diagnosis of neurodegenerative diseases: Status and challenges

Application of Iron Oxide Nanoparticles in the Diagnosis and Treatment of Neurodegenerative Diseases With Emphasis on Alzheimer’s Disease

Nanomaterials for neurodegenerative diseases: Molecular mechanisms guided design and applications

Nanotheranostic Applications for Detection and Targeting Neurodegenerative Diseases

Advances in nanomedicines for diagnosis of central nervous system disorders

Emerging nanotechnology for Alzheimer's disease: From detection to treatment

Application of Nanocomposites and Nanoparticles in Treating Neurodegenerative Disorders

Nanomaterials Toward the Treatment of Alzheimer’s Disease:Recent Advances and Future Trends

Nanomaterials that Aid in the Diagnosis and Treatment of Alzheimer's Disease, Resolving Blood-Brain Barrier Crossing Ability

Functional Nanomaterials for the Diagnosis of Alzheimer's Disease: Recent Progress and Future Perspectives

Nanomaterials for the treatment and diagnosis of Alzheimer's disease: An overview

Applications of nanodiamonds in the diagnosis and treatment of neurological diseases

Magnetic Resonance Imaging Studies of Neurodegenerative Disease: from Methods to Translational Research

Nanotheranostic agents for neurodegenerative diseases

Harnessing Two-Dimensional Nanomaterials for Diagnosis and Therapy in Neurodegenerative Diseases: Advances, Challenges and Prospects

Research Progress of Novel Inorganic Nanomaterials in the Diagnosis and Treatment of Alzheimer's Disease

Research Progress of Novel Inorganic Nanomaterials in the Diagnosis and Treatment of Alzheimer’s Disease

Functional nanoassemblies for the diagnosis and therapy of Alzheimer's diseases